Eko Health Raises $41M to Scale AI-driven Heart, Lung Detection
Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced a successful Series D financing round of $41M.
Stay updated with breaking news from Double Point Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced a successful Series D financing round of $41M.
Boston US life science company Cerevance, which has facilities at Cambridge Science Park, has taken its Series B-1 round to a stunning $98 million after securing a $47m extension.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!